Citation Impact
Citing Papers
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
2011
T Cell Ig and Mucin Domain Proteins and Immunity
2010
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Acute kidney injury
2012 Standout
Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
2007
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Accelerated Course of Experimental Autoimmune Encephalomyelitis in PD-1-Deficient Central Nervous System Myelin Mutants
2009
Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
2016
Serum biomarkers in idiopathic pulmonary fibrosis
2010
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
2013
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Renal replacement therapy in acute kidney injury: controversy and consensus
2015
The changing landscape of atherosclerosis
2021 StandoutNature
Immunoregulatory functions of mTOR inhibition
2009
Sepsis: a roadmap for future research
2015
PD‐1 signaling in primary T cells
2009
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Acute kidney injury
2019 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Sepsis and septic shock
2018 Standout
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock
2009
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
The effects of PDL-Ig on collagen-induced arthritis
2009
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
2015
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Monocytes and macrophages: developmental pathways and tissue homeostasis
2014
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
2017
Management of Sepsis During MARS Treatment in Acute on Chronic Liver Failure
2011
Colony stimulating factors and myeloid cell biology in health and disease
2012
Idiopathic pulmonary fibrosis
2011 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
2013
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
2014 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Striking Dichotomy of PD-L1 and PD-L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In Vivo
2007
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
PD‐1 signalling in CD4+ T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide‐induced tolerance
2010
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
2015
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Role of the PD-1 Pathway in the Immune Response
2012
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Regulated Compartmentalization of Programmed Cell Death-1 Discriminates CD4+CD25+ Resting Regulatory T Cells from Activated T Cells
2006
Enhanced suppressor function of TIM‐3+FoxP3+ regulatory T cells
2014
The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency
2009
Nanomaterials for In Vivo Imaging
2017
Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity
2020
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
A critical role for the programmed death ligand 1 in fetomaternal tolerance
2005
Inflammation in Atherosclerosis
2012 Standout
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo
2011
Cutting Edge: Programmed Death-1 Defines CD8+CD122+ T Cells as Regulatory versus Memory T Cells
2010
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis
2006
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
2007 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Macrophages are required for neonatal heart regeneration
2014
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease
2016
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Immune checkpoint inhibitors in challenging populations
2017
Works of Takuya Ueno being referenced
PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection
2007
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
2007
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
2007
Significance of Serum Vascular Endothelial Growth Factor Level in Patients with Idiopathic Pulmonary Fibrosis
2010
The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model
2008
PET/MRI of Inflammation in Myocardial Infarction
2012
A Novel Alloantigen-Specific CD8+PD1+ Regulatory T Cell Induced by ICOS-B7h Blockade In Vivo
2007
Intact B 7‐H 3 signaling promotes allograft prolongation through preferential suppression of T h1 effector responses
2012
Nanoparticle PET-CT Detects Rejection and Immunomodulation in Cardiac Allografts
2013
Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo
2005
Endoscopic Time-Lapse Imaging of Immune Cells in Infarcted Mouse Hearts
2013
Extramedullary Hematopoiesis Generates Ly-6C high Monocytes That Infiltrate Atherosclerotic Lesions
2011
TIM-3: A Novel Regulatory Molecule of Alloimmune Activation
2010
Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction
2010